Home Patient Care Home School of Medicine Research at NYU Administration CONTACT DIRECTORY LOOKUP

 

 
  Personal Info Research Info Contact Info Publications
 
 
 
 
Clinical Microbiology and the Challenge of Tuberculosis
Bruce A. Hanna Ph.D.
Departments of Pathology (Clinical) and Microbiology and Labs (Pathology)
 
Research Summary
Tuberculosis is the leading cause of death world today, and it is estimated that currently one third of the world population is infected. In the late 1980 s, after decades of decline in the US, we experienced a dramatic increase in the incidence of tuberculosis as well as other mycobacterial diseases. In urban areas such as New York City, the alarming increase in not only the number of cases, but the emergence of multi drug resistant strains caused clinical microbiologists to seek new and more rapid methods to detect and characterize the tubercule bacillus. Our laboratory uses the resources of the Clinical Microbiology and Immunology Laboratories at Bellevue Hospital to provide a study base for the development and evaluation of novel and rapid methods for the microbiologic diagnosis of tuberculosis.

We have participated in clinical trials of several new methods such as Ligase Chain Reaction (LCX) and the Mycobacteria Growth Indicator Tube (MGIT) systems. In the study of the later, we observed that the time to detection of Mycobacterium tuberculosis from sputum cultures correlates with clinical outcome. For patients in whom a poor clinical outcome was noted, the TTD remained constant and brief during the course of their disease. Conversely, for patients in whom the clinical outcome was good the TTD increased as therapy progressed. This indicator appears to be more a more reliable indicator of clinical outcome than the commonly used AFB sputum smear result, and may become a useful adjunct to predict outcome in tuberculosis patients.

Related Images

Image 1

Patients with TTD <20 vs treatment duration. For each 10-day period, the number of patients with one or more cultures with a TTD <20 days is shown by group. The presence of one or more cultures with a TTD <20 decreased more rapidly in group 1 patients (good clinical responders) compared with group 2 patients (poor clinical responders).

Research Information

Research Interests

Clinical Microbiology and the Challenge of Tuberculosis

Research Keywords

laboratory detection, patient outcome, tuberculosis

 

 

New York University School of Medicine
550 First Avenue, New York, NY 10016
© 2001 New York University
(212) 263-7300
Contact the Webmaster
Ethics and Disclaimer
NYU Home
SoM Home Search Directories SoM Partners School Home